Clinical trial Recruiting at 1 site Interventional Ages 35 to 75 Women only

Women with chest pain and non-obstructive arteries: personalized diagnostic and treatment approach

Official title: Invasive Functional and Morphological Coronary Assessment Followed by Phenotype-Guided Multidisciplinary Treatment in Women With Angina and Non-Obstructive Coronary Arteries: A Prospective Single-Center Interventional Study

Run by Hospital de Clínicas Dr. Manuel Quintela · NCT07593157 · Data updated 2026-11-12

This study tests a personalized diagnostic-and-treatment pathway for women with angina but non-obstructive coronary arteries to see if targeted therapy improves symptoms and quality of life.

More Coronary Microvascular Dysfunction trials

Quick facts

Study typeInterventional
Ages35 Years to 75 Years
SexWomen only
Enrollment50 (estimated)
SponsorHospital de Clínicas Dr. Manuel Quintela
Academic / other
Locations1 site (Montevideo, Montevideo Department)
StatusRecruiting
StartedMay 15, 2026
Main results expectedApril 30, 2029
Study endsApril 30, 2029
Registry record updatedNovember 4, 2026
Trial IDNCT07593157 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 35–75 with stable angina or suspected ischemia and non-obstructive arteries (no stenosis ≥50%), able to undergo invasive assessment and follow-up.

Probably not a fit

Patients without a specific phenotype identified or those unable to adhere to the follow-up may see limited benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-center study, women with angina and non-obstructive coronary arteries undergo an invasive assessment that combines physiology testing, acetylcholine provocation, and intracoronary imaging to identify the dominant mechanism of angina. Based on the phenotype identified, participants receive individualized pharmacologic and lifestyle therapies, with psycho-emotional support as needed. Follow-up visits at 1, 6, and 12 months monitor angina symptoms, quality of life, exercise capacity, treatment adherence, and cardiovascular events. The goal is to establish a structured diagnostic and therapeutic pathway for ANOCA and related conditions at a Uruguayan academic center.

Why it matters

Potential benefit: If successful, the approach could lead to more accurate diagnosis and tailored treatment, potentially reducing symptoms and improving quality of life for women with ANOCA.

How similar studies have gone: Prior research supports the value of phenotype-guided management in ANOCA, but evidence is still evolving and this single-center study adds contemporary, procedure-based personalization.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female participants aged 35 to 75 years.
* Symptoms compatible with stable angina or suspected myocardial ischemia.
* Non-obstructive coronary arteries, defined as absence of angiographic stenosis greater than or equal to 50%.
* Ability to undergo invasive coronary assessment and clinical follow-up.
* Written informed consent.

Exclusion Criteria:

* Significant structural heart disease.
* Severe left ventricular systolic dysfunction, defined as left ventricular ejection fraction \<40%.
* Clinically relevant contraindication to adenosine or acetylcholine, including severe asthma, untreated high-grade atrioventricular block, or known hypersensitivity.
* Active oncological disease or life expectancy less than 12 months.
* Inability to complete the diagnostic or therapeutic study protocol.
* Participation in another clinical study that could interfere with the present protocol.

Where it's running

  • Hospital de Clínicas Dr. Manuel Quintela
    Montevideo, Montevideo Department, Uruguay
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.